Cosmos Health’s C-Scrub Wash 4% Clears EN 12791 Standard, Opening Hospital and Surgical Channels
Cosmos Health’s C-Scrub Wash 4%, formulated with 4% Chlorhexidine Digluconate, has passed EN 12791:2016+A1:2017 surgical hand disinfection standards, confirming effective antimicrobial activity. The milestone supports entry into hospital, surgical, and professional healthcare markets and strengthens the company’s UK and international expansion strategy.
1. EN 12791 Study Success
C-Scrub Wash 4% demonstrated effective antimicrobial activity under the EN 12791:2016+A1:2017 surgical hand disinfection standard, reflecting technical parity with leading antiseptic benchmarks. The study confirms the product’s suitability for critical infection control in surgical settings.
2. Expanded Healthcare Market Access
Achieving EN 12791 compliance unlocks entry into hospital, surgical, and professional healthcare channels by meeting European regulatory requirements for surgical antiseptics. This milestone lowers barriers to institutional adoption and strengthens the product’s clinical positioning.
3. Strengthened UK and International Expansion
The company has recently broadened C-Scrub availability in the United Kingdom and is leveraging this technical endorsement to pursue new contracts across Europe and other global markets. This strategic rollout aims to drive sales growth and elevate the C-Scrub brand.